Revolutionizing Stroke Prevention: InspireMD’s CGuard® Prime and the Future of Carotid Stenting episode artwork

EPISODE · Sep 29, 2025 · 19 MIN

Revolutionizing Stroke Prevention: InspireMD’s CGuard® Prime and the Future of Carotid Stenting

from WTR Small-Cap Spotlight

Send us Fan MailIn this episode of WTR Small-Cap Spotlight, host Tim Gerdeman and WTR’s Robert Sassoon speak with Marvin Slosman, CEO of InspireMD (NASDAQ: NSPR), to discuss how the company is transforming carotid artery disease treatment with its groundbreaking CGuard® Prime Carotid Stent System. The conversation covers FDA approval, clinical data, market adoption, competitive positioning, and InspireMD’s long-term growth strategy.

Episode metadata supplied by the publisher feed · Published Sep 29, 2025

Embed this episode

NOW PLAYING

Revolutionizing Stroke Prevention: InspireMD’s CGuard® Prime and the Future of Carotid Stenting

0:00 19:15

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of WTR Small-Cap Spotlight?

This episode is 19 minutes long.

When was this WTR Small-Cap Spotlight episode published?

This episode was published on September 29, 2025.

Can I download this WTR Small-Cap Spotlight episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!